Glibenclamide
CLINICAL USE
Non-insulin dependent diabetes mellitus
DOSE IN NORMAL RENAL FUNCTION
Initially 5 mg daily (elderly patients – 2.5 mg) adjusted according to response; maximum 15 mg daily
PHARMACOKINETICS
DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs
ADMINISTRATION
Reconstition
–
Route
Oral
Rate of Administration
–
Comments
Take with breakfast
OTHER INFORMATION
Metabolites of glibenclamide are only weakly hypoglycaemic; this is not clinically relevant where renal and hepatic functions are normal. If creatinine clearance